- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-12-mer
- Ligands
- 24 x FE: FE (III) ION(Non-covalent)(Non-functional Binders)
- 48 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 5 residues within 4Å:- Chain A: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.4: 1 residues within 4Å:- Ligands: EDO.58
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: F.38, E.65, A.68
- Chain J: F.38, E.65, A.68
- Ligands: EDO.59
Ligand excluded by PLIPEDO.6: 1 residues within 4Å:- Chain A: T.102
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain B: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.10: 1 residues within 4Å:- Ligands: EDO.28
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain B: F.38, E.65, A.68
- Chain E: F.38, E.65, A.68
- Ligands: EDO.29
Ligand excluded by PLIPEDO.12: 1 residues within 4Å:- Chain B: T.102
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain C: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.16: 1 residues within 4Å:- Ligands: EDO.52
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain C: F.38, E.65, A.68
- Chain I: F.38, E.65, A.68
- Ligands: EDO.53
Ligand excluded by PLIPEDO.18: 1 residues within 4Å:- Chain C: T.102
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain D: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.22: 1 residues within 4Å:- Ligands: EDO.40
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain D: F.38, E.65, A.68
- Chain G: F.38, E.65, A.68
- Ligands: EDO.41
Ligand excluded by PLIPEDO.24: 1 residues within 4Å:- Chain D: T.102
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain E: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.28: 1 residues within 4Å:- Ligands: EDO.10
Ligand excluded by PLIPEDO.29: 7 residues within 4Å:- Chain B: F.38, E.65, A.68
- Chain E: F.38, E.65, A.68
- Ligands: EDO.11
Ligand excluded by PLIPEDO.30: 1 residues within 4Å:- Chain E: T.102
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain F: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.34: 1 residues within 4Å:- Ligands: EDO.70
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain F: F.38, E.65, A.68
- Chain L: F.38, E.65, A.68
- Ligands: EDO.71
Ligand excluded by PLIPEDO.36: 1 residues within 4Å:- Chain F: T.102
Ligand excluded by PLIPEDO.39: 5 residues within 4Å:- Chain G: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.40: 1 residues within 4Å:- Ligands: EDO.22
Ligand excluded by PLIPEDO.41: 7 residues within 4Å:- Chain D: F.38, E.65, A.68
- Chain G: F.38, E.65, A.68
- Ligands: EDO.23
Ligand excluded by PLIPEDO.42: 1 residues within 4Å:- Chain G: T.102
Ligand excluded by PLIPEDO.45: 5 residues within 4Å:- Chain H: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.46: 1 residues within 4Å:- Ligands: EDO.64
Ligand excluded by PLIPEDO.47: 7 residues within 4Å:- Chain H: F.38, E.65, A.68
- Chain K: F.38, E.65, A.68
- Ligands: EDO.65
Ligand excluded by PLIPEDO.48: 1 residues within 4Å:- Chain H: T.102
Ligand excluded by PLIPEDO.51: 5 residues within 4Å:- Chain I: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.52: 1 residues within 4Å:- Ligands: EDO.16
Ligand excluded by PLIPEDO.53: 7 residues within 4Å:- Chain C: F.38, E.65, A.68
- Chain I: F.38, E.65, A.68
- Ligands: EDO.17
Ligand excluded by PLIPEDO.54: 1 residues within 4Å:- Chain I: T.102
Ligand excluded by PLIPEDO.57: 5 residues within 4Å:- Chain J: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.58: 1 residues within 4Å:- Ligands: EDO.4
Ligand excluded by PLIPEDO.59: 7 residues within 4Å:- Chain A: F.38, E.65, A.68
- Chain J: F.38, E.65, A.68
- Ligands: EDO.5
Ligand excluded by PLIPEDO.60: 1 residues within 4Å:- Chain J: T.102
Ligand excluded by PLIPEDO.63: 5 residues within 4Å:- Chain K: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.64: 1 residues within 4Å:- Ligands: EDO.46
Ligand excluded by PLIPEDO.65: 7 residues within 4Å:- Chain H: F.38, E.65, A.68
- Chain K: F.38, E.65, A.68
- Ligands: EDO.47
Ligand excluded by PLIPEDO.66: 1 residues within 4Å:- Chain K: T.102
Ligand excluded by PLIPEDO.69: 5 residues within 4Å:- Chain L: I.63, G.66, F.67, M.70, Y.119
Ligand excluded by PLIPEDO.70: 1 residues within 4Å:- Ligands: EDO.34
Ligand excluded by PLIPEDO.71: 7 residues within 4Å:- Chain F: F.38, E.65, A.68
- Chain L: F.38, E.65, A.68
- Ligands: EDO.35
Ligand excluded by PLIPEDO.72: 1 residues within 4Å:- Chain L: T.102
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tsuruta, O. et al., A new crystal lattice structure of Helicobacter pylori neutrophil-activating protein (HP-NAP). Acta Crystallogr.,Sect.F (2012)
- Release Date
- 2012-02-08
- Peptides
- Neutrophil-activating protein: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-12-mer
- Ligands
- 24 x FE: FE (III) ION(Non-covalent)(Non-functional Binders)
- 48 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tsuruta, O. et al., A new crystal lattice structure of Helicobacter pylori neutrophil-activating protein (HP-NAP). Acta Crystallogr.,Sect.F (2012)
- Release Date
- 2012-02-08
- Peptides
- Neutrophil-activating protein: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
A